We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+9.21%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$2.75B
AUM Growth
+$188M
Cap. Flow
+$19.8M
Cap. Flow %
0.72%
Top 10 Hldgs %
19.69%
Holding
327
New
32
Increased
100
Reduced
149
Closed
29

Top Buys

Rank Stock Value
1
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
+$19.1M
2
APOG icon
Apogee Enterprises
APOG
+$15.9M
3
DNOW icon
DNOW Inc
DNOW
+$15.1M
4
PINC
Premier
PINC
+$13.4M
5
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$12.4M

Top Sells

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$25.9M
2
STMP
Stamps.com, Inc.
STMP
+$17.4M
3
VSAT icon
Viasat
VSAT
+$17M
4
CVGW
Calavo Growers
CVGW
+$15.3M
5
REVG
REV Group
REVG
+$15.1M

Sector Composition

Rank Sector Weight
1 Healthcare 22.97%
2 Industrials 19.87%
3 Technology 17.13%
4 Consumer Discretionary 9.66%
5 Communication Services 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENSG icon
76
The Ensign Group
ENSG
$10.6B
$13.9M 0.51%
415,671
-362,869
-47% -$11.2M
MSM icon
77
MSC Industrial Direct
MSM
$6.91B
$13.7M 0.5%
161,904
+6,263
+4% +$567K
SLCA
78
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$13.6M 0.49%
528,168
+50,364
+11% +$1.48M
IT icon
79
Gartner
IT
$12B
$12.9M 0.47%
97,385
+3,709
+4% +$475K
AZTA icon
80
Azenta
AZTA
$1.44B
$12.2M 0.44%
372,485
+306,110
+461% +$9.12M
TSEM icon
81
Tower Semiconductor
TSEM
$28.1B
$11.6M 0.42%
525,201
-51,076
-9% -$1.3M
SUM
82
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$11.5M 0.42%
+446,593
New +$12.4M
PLCE icon
83
Children's Place
PLCE
$60.5M
$11.2M 0.41%
+93,037
New +$12.1M
BECN
84
DELISTED
Beacon Roofing Supply, Inc.
BECN
$11.2M 0.41%
263,415
-11,661
-4% -$537K
PGNX
85
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$11.2M 0.41%
1,389,840
+15,378
+1% +$117K
OPLN
86
Openlane
OPLN
$4.66B
$11.1M 0.4%
535,187
+397,576
+289% +$8.1M
MRCY icon
87
Mercury Systems
MRCY
$6.5B
$11M 0.4%
+288,735
New +$11.2M
PCRX icon
88
Pacira BioSciences
PCRX
$1B
$10.8M 0.39%
338,032
+12,161
+4% +$420K
LKQ icon
89
LKQ Corp
LKQ
$6.15B
$10.7M 0.39%
335,548
+53,996
+19% +$1.8M
AQUA
90
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$10.6M 0.38%
+515,076
New +$10.5M
COLL icon
91
Collegium Pharmaceutical
COLL
$936M
$10.4M 0.38%
436,510
+53,530
+14% +$1.32M
PBYI icon
92
Puma Biotechnology
PBYI
$435M
$10.3M 0.38%
174,757
+6,793
+4% +$394K
NTCT icon
93
NETSCOUT
NTCT
$2.85B
$10.3M 0.37%
+347,121
New +$9.65M
VRNT
94
DELISTED
Verint Systems
VRNT
$10.2M 0.37%
+450,691
New +$9.8M
LNN icon
95
Lindsay Corp
LNN
$1.19B
$9.96M 0.36%
+102,643
New +$9.66M
NGVT icon
96
Ingevity
NGVT
$2.68B
$9.94M 0.36%
122,948
+3,353
+3% +$266K
MDSO
97
DELISTED
Medidata Solutions, Inc.
MDSO
$9.82M 0.36%
+121,903
New +$9.14M
COHR icon
98
Coherent
COHR
$74.5B
$9.71M 0.35%
+223,368
New +$9.86M
CARS icon
99
Cars.com
CARS
$733M
$9.68M 0.35%
+341,105
New +$9.38M
FCFS icon
100
FirstCash
FCFS
$8.91B
$9.59M 0.35%
106,675
-45,213
-30% -$4M
2 3
4
5 6

Similar funds

GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return
CIM
Cambria Investment Management Manhattan Beach, California $1.79B AUM 28.1% 1-Year Est. Return
KPM
Kinetic Partners Management Miami, Florida $1.79B AUM 57.3% 1-Year Est. Return
EFS
Essex Financial Services Essex, Connecticut $1.78B AUM 23.37% 1-Year Est. Return
OAM
Ostrum Asset Management Paris, France $1.78B AUM 27.8% 1-Year Est. Return
UF
Univest Financial Souderton, Pennsylvania $1.78B AUM 22.52% 1-Year Est. Return
BCMIO
Beacon Capital Management Inc (Ohio) Dayton, Ohio $1.78B AUM 14.7% 1-Year Est. Return

Rice Hall James & Associates's Q2 2018 Portfolio in Review

As of Q2 2018, Rice Hall James & Associates held 327 positions worth $2.75B, up 7.3% from $2.56B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Rice Hall James & Associates's Q2 2018 filing shows 32 new, 100 increased, 149 reduced and 29 closed positions. Its largest new stake was DIPLOMAT PHARMACY, INC.: 818,939 shares worth $20.9M. The largest sale was Supernus Pharmaceuticals, an estimated $25.9M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.

  • Rice Hall James & Associates's largest Q2 2018 buy was DIPLOMAT PHARMACY, INC.: 818,939 shares worth $20.9M.
  • Rice Hall James & Associates added most to Apogee Enterprises in Q2 2018, an estimated $15.9M increase.
  • Rice Hall James & Associates's biggest Q2 2018 reduction was Supernus Pharmaceuticals, cutting an estimated $25.9M.
  • Rice Hall James & Associates fully exited Viasat in Q2 2018, selling an estimated $17M.
  • Rice Hall James & Associates's ten largest holdings make up 20% of its $2.75B portfolio in Q2 2018.
  • Rice Hall James & Associates opened 32 new positions and closed 29 in Q2 2018.
  • Rice Hall James & Associates's portfolio value rose 7.3% quarter-over-quarter to $2.75B.

Based on Rice Hall James & Associates's 13F filing for Q2 2018, filed 2 Aug 2018.